Activation of the adenosine A2A receptor attenuates experimental autoimmune myasthenia gravis severity (Q84007875)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539289%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

title

Activation of the adenosine A2A receptor attenuates experimental autoimmune myasthenia gravis severity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539289%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference

Na Li

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539289%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Lili Mu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539289%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Jinghua Wang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539289%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Jia Zhang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539289%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Xiaoli Xie

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539289%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Qingfei Kong

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539289%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Wei Tang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539289%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Xiuhua Yao

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539289%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Yumei Liu

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539289%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Lihua Wang

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539289%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Guangyou Wang

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539289%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Dandan Wang

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539289%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Lianhong Jin

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539289%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Bo Sun

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539289%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Hulun Li

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539289%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

publication date

1 May 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539289%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

30 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539289%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539289%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539289%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

1140-1151

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539289%20AND%20SRC:MED&resulttype=core&format=json

Ectopic GC in the thymus of myasthenia gravis patients show characteristics of normal GC

30 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142088

7 January 2021

Unravelling the pathogenesis of myasthenia gravis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142088

7 January 2021

Naturally occurring anti-idiotypic antibodies in myasthenia gravis patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142088

7 January 2021

Breakdown of tolerance to a self-peptide of acetylcholine receptor alpha-subunit induces experimental myasthenia gravis in rats

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142088

7 January 2021

Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142088

7 January 2021

The susceptibility to experimental myasthenia gravis of STAT6-/- and STAT4-/- BALB/c mice suggests a pathogenic role of Th1 cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142088

7 January 2021

C57BL/6 mice genetically deficient in IL-12/IL-23 and IFN-gamma are susceptible to experimental autoimmune myasthenia gravis, suggesting a pathogenic role of non-Th1 cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142088

7 January 2021

T Cells and Cytokines in the Pathogenesis of Acquired Myasthenia Gravis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142088

7 January 2021

Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142088

7 January 2021

Expansion of regulatory T cells via IL-2/anti-IL-2 mAb complexes suppresses experimental myasthenia

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142088

7 January 2021

The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142088

7 January 2021

Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142088

7 January 2021

Disequilibrium of T helper type 1, 2 and 17 cells and regulatory T cells during the development of experimental autoimmune myasthenia gravis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142088

7 January 2021

Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142088

7 January 2021

Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142088

7 January 2021

Selective inactivation or reconstitution of adenosine A2A receptors in bone marrow cells reveals their significant contribution to the development of ischemic brain injury

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142088

7 January 2021

Adenosine receptors: therapeutic aspects for inflammatory and immune diseases

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142088

7 January 2021

Analysis of A2a receptor-deficient mice reveals no significant compensatory increases in the expression of A2b, A1, and A3 adenosine receptors in lymphoid organs

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142088

7 January 2021

Abnormal adenosine-induced immunosuppression and cAMP metabolism in T lymphocytes of patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142088

7 January 2021

Adenosine 2A receptor availability in dyskinetic and nondyskinetic patients with Parkinson disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142088

7 January 2021

CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142088

7 January 2021

IFN-beta regulates CD73 and adenosine expression at the blood-brain barrier.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142088

7 January 2021

Polymorphisms within the adenosine receptor 2a gene are associated with adverse events in RA patients treated with MTX.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142088

7 January 2021

Activation of adenosine 2A receptors attenuates allograft rejection and alloantigen recognition

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142088

7 January 2021

Pharmacological postconditioning protects against hepatic ischemia/reperfusion injury

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142088

7 January 2021

A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142088

7 January 2021

Adenosine acts through an A3 receptor to prevent the induction of murine anti-CD3-activated killer T cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142088

7 January 2021

Cytokines and the pathogenesis of myasthenia gravis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142088

7 January 2021

Aspects of the general biology of adenosine A2A signaling.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142088

7 January 2021

A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142088

7 January 2021

A2A adenosine receptor may allow expansion of T cells lacking effector functions in extracellular adenosine-rich microenvironments

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142088

7 January 2021

Adenosine A2A receptor activation inhibits T helper 1 and T helper 2 cell development and effector function.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142088

7 January 2021

CD4+CD25+ regulatory T cells in autoimmune arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142088

7 January 2021

BM stromal cells ameliorate experimental autoimmune myasthenia gravis by altering the balance of Th cells through the secretion of IDO.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142088

7 January 2021

Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142088

7 January 2021

Identifiers

DOI

10.1002/EJI.201142088

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539289%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference